Facial resurfacing with coblation technology.

Medscape journal of medicine Pub Date : 2008-07-02
Stephen M Weber, Brian W Downs, Mario B J Ferraz, Tom D Wang, Ted A Cook
{"title":"Facial resurfacing with coblation technology.","authors":"Stephen M Weber,&nbsp;Brian W Downs,&nbsp;Mario B J Ferraz,&nbsp;Tom D Wang,&nbsp;Ted A Cook","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To describe our experience with coblation technology for facial resurfacing</p><p><strong>Methods: </strong>Retrospective chart review of all patients treated with coblation at our institution</p><p><strong>Results: </strong>Twenty-four patients (22 female) underwent a total of 29 coblation procedures for aging face (n = 21) or acne scarring (n = 3). The perioral region was the most frequently treated aesthetic subunit (n = 14), followed by the lower eyelid (n = 7). Five patients underwent full-face coblation. Three patients underwent a second coblation procedure for aging face while a single patient with severe acne scarring underwent 3 procedures. Repeat coblation was delayed at least 5 months (mean, 9 months). Seventeen coblation procedures (59%) were performed concurrently with procedures including, but not limited to, injection treatment, rhinoplasty, blepharoplasty, or combined face/necklift; no adverse events occurred. Seven procedures, including a full-face coblation, were performed in the office under local anesthesia and oral sedation without any adverse events. Mean follow-up was 6 months (range, 1 week to 24 months). No complications were observed. All patients were satisfied with the results after their final coblation treatment.</p><p><strong>Conclusions: </strong>Facial coblation is a safe and effective treatment modality for facial resurfacing.</p>","PeriodicalId":87690,"journal":{"name":"Medscape journal of medicine","volume":"10 7","pages":"155"},"PeriodicalIF":0.0000,"publicationDate":"2008-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2525463/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medscape journal of medicine","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: To describe our experience with coblation technology for facial resurfacing

Methods: Retrospective chart review of all patients treated with coblation at our institution

Results: Twenty-four patients (22 female) underwent a total of 29 coblation procedures for aging face (n = 21) or acne scarring (n = 3). The perioral region was the most frequently treated aesthetic subunit (n = 14), followed by the lower eyelid (n = 7). Five patients underwent full-face coblation. Three patients underwent a second coblation procedure for aging face while a single patient with severe acne scarring underwent 3 procedures. Repeat coblation was delayed at least 5 months (mean, 9 months). Seventeen coblation procedures (59%) were performed concurrently with procedures including, but not limited to, injection treatment, rhinoplasty, blepharoplasty, or combined face/necklift; no adverse events occurred. Seven procedures, including a full-face coblation, were performed in the office under local anesthesia and oral sedation without any adverse events. Mean follow-up was 6 months (range, 1 week to 24 months). No complications were observed. All patients were satisfied with the results after their final coblation treatment.

Conclusions: Facial coblation is a safe and effective treatment modality for facial resurfacing.

用消融技术进行面部重塑。
结果:24例(22例女性)因面部老化(n = 21)或痤疮疤痕(n = 3)接受了29次面部消融手术。口腔周围区域是最常治疗的美容亚单位(n = 14),其次是下眼睑(n = 7)。5例患者接受了全脸消融。三名患者接受了第二次面部消融手术,而一名严重痤疮疤痕的患者接受了三次手术。重复消融至少延迟5个月(平均9个月)。17例消融手术(59%)与包括但不限于注射治疗、鼻成形术、眼睑成形术或面部/颈部联合提拉术等手术同时进行;无不良事件发生。在局麻和口服镇静的情况下,在办公室进行了包括全脸消融在内的七个手术,没有发生任何不良事件。平均随访6个月(1周到24个月)。无并发症发生。所有患者在最后的消融治疗后均满意。结论:面部消融是一种安全有效的治疗方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书